A. V. Kachko

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity

Pei Zhang, Lilin Zhong, Evi Struble et al. · Proceedings of the National Academy of Sciences · 2009 · 139 citations · Full text

Hcv Neutralization, Humoral Response, Immunology +16

Inhibition of Hepatitis C Virus by the Cyanobacterial Protein <i>Microcystis viridis</i> Lectin: Mechanistic Differences between the High-Mannose Specific Lectins MVL, CV-N, and GNA

A. V. Kachko, Sandra Loesgen, Syed Shahzad‐ul‐Hussan et al. · Molecular Pharmaceutics · 2013 · 47 citations · Full text

Mechanistic Differences, Microbial Pathogens, Hepatitis C Virus +16

Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users

Marian Major, Alexander Gutfraind, Louis Shekhtman et al. · Science Translational Medicine · 2018 · 45 citations · Full text

Immunology, Vaccine Hesitancy, Viral Hepatitis +16

New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles

A. V. Kachko, G. F. Sivolobova, Iryna Zubkova et al. · Vaccine · 2011 · 34 citations

Viral Hepatitis, Immunology, Glycobiology +10

Genetic factors of Ebola virus virulence in guinea pigs

Ekaterina Subbotina, A. A. Dadaeva, A. V. Kachko · Virus Research · 2010 · 33 citations

Pathogenesis, Immunology, Ebola Virus Virulence +4